Award-winning! Highly Commended Certificate of the 2006 BMA Medical Book Competition
The metabolic syndrome is a highly prevalent condition that affects a considerate number of adults and has become increasingly relevant to many disciplines in clinical medicine. This title examines the pathogenesis of metabolic syndrome and its relationship with diabetes and coronary heart disease (CHD), and reviews different treatment options. It covers all aspects of the metabolic syndrome and its constituent diseases.
The editors of this key title, Christopher D. Byrne, a diabetologist and clinician scientist, and Sarah H. Wild, an epidemiologist and public health physician, have brought together a group of authors, all of who are leading researchers in their field.
The editors and chapter authors of this outstanding reference work have each contributed to chapters addressing ‘hot topics’ relevant to the metabolic syndrome. The state-of-the-art chapters range from aetiology to pathogenesis, complications and treatment, addressing subjects such as the developmental origins of the metabolic syndrome, oxidation, inflammation and exciting new areas such as non-alcoholic steatohepatitis and adipocytokines.
The Metabolic Syndrome is an invaluable resource for all clinical researchers and physicians requiring detailed up-to-date information on the metabolic syndrome. It is helpful to further their own research or to treat and manage the syndrome and its complications. The book is also of interest for all health care professionals.
From the reviews:
“... an excellent collection of updated reviews... provides a valuable background for understanding many aspects of this fascinating cluster of risk factors..." NEW ENGLAND JOURNAL OF MEDICINE
Christopher Byrne trained as a physician and clinical scientist at Cardiff, Cambridge and Stanford Universities. After Medical Research Council clinical science fellowships he was appointed Professor of Endocrinology & Metabolism at Southampton University Hospitals Trust, UK. He is an academic diabetologist with clinical and molecular research interests in the pathogenesis of the metabolic syndrome, and the mechanisms linking metabolic syndrome with type 2 diabetes and cardiovascular disease. His publications span a range of disciplines from epidemiological to gene expression studies.
Sarah Wild trained in medicine in London and Cambridge and subsequently received training in epidemiology at Stanford University and the London School of Hygiene and Tropical Medicine. She is currently senior lecturer in epidemiology at the University of Edinburgh. Her research interests include the global burden of diabetes and metabolic syndrome and cardiovascular epidemiology.
